REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Pathwork Diagnostics, Inc., a pioneer in creating genomics-based diagnostics in oncology utilizing their proprietary informatics platform, today announced the ...
Affymetrix Inc. and PathWork Informatics Inc. have announced that Affymetrix has granted PathWork long-term non-exclusive access to its microarray technology to develop and market in-vitro diagnostic ...
SUNNYVALE, Calif., July 31 /PRNewswire/ -- Pathwork Diagnostics, Inc., a molecular diagnostics company focused on oncology, today announced that the U.S. Food and Drug Administration (FDA) has cleared ...
SAN FRANCISCO, Oct. 20, 2025 /PRNewswire/ -- Pathwork, the AI-native platform modernizing the $160 billion life and health insurance market, today announced a strategic partnership with AIMCOR Group, ...
Federal regulators said Thursday that they have given Pathwork Diagnostics of Sunnyvale permission to begin selling a new genetic test to determine what type of cancer cells are in a malignant tumor.
Whether you’re a teenager, or raising one, adolescence is no joke. This transitional period can test relationship limits and leave teens and parents feeling hurt, confused, scared, and an array of ...
SAN FRANCISCO and MADISON, Wis., March 5, 2026 /PRNewswire/ -- Pathwork and NGL Insurance Company (NGL), in partnership with LifeCare Assurance Company, announced the launch of PreQual Manager, an ...
SUNNYVALE, Calif., Sept. 4 Pathwork Diagnostics, amolecular diagnostics company focused on oncology, announced the closing todayof a $20 million financing led by Abingworth. The announcement came on ...
Pathwork Diagnostics, a Sunnyvale, Calif.-based maker of cancer diagnostic tets, has raised $20 million in a second round of funding. The round was led by new investor Abingworth Management, with ...
Are you or someone you care about wondering if therapy might be helpful? Maybe you've thought, "I don't want to feel like this anymore, but I don't know what to do," or "Something just doesn’t feel ...
Federal regulators said today they have given Pathwork Diagnostics of Sunnyvale permission to begin selling a new genetic test to determine what type of cancer cells are in a malignant tumor. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results